Showing results (281-290 of 523) with videos related to
Sort By:
Pageof 53
Molecular Cancer Therapeutics|October 9, 2021
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant MutationsBrion W Murray, Evan Rogers, Dayong Zhai, et al.European Journal of Cancer (Oxford, England : 1990)|April 21, 2024
Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockersPierre-Louis Cariou, Cédric Pobel, Jean-Marie Michot, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2024
Final Overall Survival and Long-Term Safety of Lorlatinib in Patients With ALK-Positive NSCLC From the Pivotal Phase 2 Study: A Brief ReportSai-Hong Ignatius Ou, Benjamin J Solomon, Benjamin Besse, et al.Frontiers in Oncology|April 14, 2022
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung CancerBrendan Knapp, Laura Mezquita, Siddhartha Devarakonda, et al.NPJ Precision Oncology|July 17, 2021
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitorsMarianne Oulhen, Patrycja Pawlikowska, Tala Tayoun, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancerJulien Adam, Tony Sourisseau, Ken A Olaussen, et al.Cardiovascular and Interventional Radiology|November 7, 2019
Correction to: Focus on Recommendations for the Management of Non-small Cell Lung CancerPernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitorsRomain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.Journal of Telemedicine and Telecare|February 8, 2024
Evaluation of the satisfaction and experiences of oncology patients and doctors using teleconsultation during the COVID-19 pandemicMyrto Kastrisiou, Maryam Karimi, Evangelos Aa Christou, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2009
Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sitesCarlos Gomez-Roca, Christophe M Raynaud, Frederique Penault-Llorca, et al.Pageof 53